NCT05095493View on ClinicalTrials.gov

Oral Zinc Supplementation to Enhance Botulinum Neurotoxin Response

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Dystonia, Focal
Interventions
DIETARY_SUPPLEMENT

Zinc Acetate

50 mg tablet

DIETARY_SUPPLEMENT

Placebo

Zinc Acetate matched placebo tablet

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT05095493 - Oral Zinc Supplementation to Enhance Botulinum Neurotoxin Response | Biotech Hunter | Biotech Hunter